Forward Citations = 0

Loading Chart...

3 inventors (with patents filed for the assignee):

Russell Killingsworth (14 out of 14 patents)

Cara Elizabeth Wessels Wells (13 out of 13 patents)

Cara Wells (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12602785 - Training a machine learning model to assess embryo characteristics from video image data (2026-04-14),

2. 12236588 - Bovine embryo evaluation using AI/ML analysis of real-time video for predicting male-sex offspring (2025-02-25),

3. 12205283 - Embryo evaluation using AI/ML analysis of real-time video for predicting offspring sex (2025-01-21),

4. 12205282 - Bovine embryo evaluation using AI/ML analysis of real-time video for predicting female-sex offspring (2025-01-21),

5. 12205281 - Human embryo evaluation using AI/ML analysis of real-time video for predicting female-sex offspring (2025-01-21),

6. 12205280 - Human embryo evaluation using AI/ML analysis of real-time video for predicting male-sex offspring (2025-01-21),

7. 11645751 - Bovine embryo evaluation using AI/ML analysis of real-time frame speed video for predicting male-sex offspring (2023-05-09),

8. 11645750 - Human embryo evaluation using AI/ML analysis of real-time frame speed video for predicting female-sex offspring (2023-05-09),

9. 11636595 - Bovine embryo evaluation using AI/ML analysis of real-time frame speed video for predicting female-sex offspring (2023-04-25),

10. 11620750 - Embryo evaluation based on real-time video (2023-04-04),

11. 11494912 - Human embryo evaluation using AI/ML analysis of real-time frame speed video for predicting male-sex offspring (2022-11-08),

12. 11494911 - Embryo evaluation using AI/ML analysis of real-time frame speed video for predicting offspring sex (2022-11-08),

13. 11494910 - Embryo viability evaluation using AI/ML analysis of short duration video (2022-11-08),

14. 11455725 - Embryo viability evaluation using AI/ML analysis of real-time video (2022-09-27),

Company Overview

Emgenisys, Inc. is a Houston-based company specializing in advanced biotechnology solutions. The organization focuses on the development of innovative therapeutic platforms and diagnostic tools aimed at addressing complex medical challenges. With a commitment to enhancing healthcare outcomes, Emgenisys leverages cutting-edge research in molecular biology and genetic engineering. The company's work is pivotal in the fields of personalized medicine and targeted therapies, contributing to the evolving landscape of modern healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#366 in Houston, TX

#1,378 in Texas

#22,319 in US

#42,249 in the World

Houston, TX, United States of America

Emgenisys, Inc.

Forward Citations = 0

3 inventors:

Russell Killingsworth (14 out of 14 patents)

Cara Elizabeth Wessels Wells (13 out of 13 patents)

Cara Wells (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emgenisys, Inc.. Retrieved from https://idiyas.com/company/emgenisys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]